White label – Pompe disease - ClinicalTrials.eu

Study Comparing Elranatamab and Lenalidomide for Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+8
Study for Patients with Metastatic Colorectal Cancer with BRAF V600E Mutation Using Encorafenib, Cetuximab, and Chemotherapy Combination

Not recruiting

3 1 1 1
Investigated Drugs:
+7
Study on Long-Term Effects of Lerodalcibep for Lowering Cholesterol in Patients with Familial Hypercholesterolemia or Cardiovascular Disease Risks

Not recruiting

3 1 1
Investigated Diseases:
- Type IIa hyperlipidaemia
- Cardiovascular disorder
Investigated Drugs:
- Lerodalcibep
Study Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma

Not recruiting

4 1 1 1
Investigated Diseases:
- Malignant melanoma
- Metastatic malignant melanoma
Investigated Drugs:
- Nivolumab
- Relatlimab
+7
Study on the Effects of Rusfertide (PTG-300) for Patients with Polycythemia Vera

Not recruiting

3 1
Investigated Diseases:
- Polycythaemia vera
Investigated Drugs:
- Rusfertide
+5
Study Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
+10
Study on the Effects of Human Normal Immunoglobulin in Adults with Dermatomyositis

Not recruiting

3 1 1
Investigated Drugs:
- Human Normal Immunoglobulin
+1
Study on Patidegib Gel for Reducing Basal Cell Carcinomas in Adults with Gorlin Syndrome

Not recruiting

3 1
Investigated Diseases:
- Basal cell naevus syndrome
Investigated Drugs:
- Patidegib Hydrochloride Isopropanolate
Study on Idiopathic Pulmonary Fibrosis: Evaluating Pirfenidone and Nintedanib for Patients with Progressive Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Idiopathic pulmonary fibrosis
Investigated Drugs:
- Nintedanib
- Pirfenidone
Study of Axitinib and Immune Checkpoint Inhibitors for Patients with Untreated Advanced or Metastatic Kidney Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Metastatic renal cell carcinoma
- Renal cell carcinoma

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies